Live Breaking News & Updates on Incyte

Stay informed with the latest breaking news from Incyte on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Incyte and stay connected to the pulse of your community

Grimes & Company Inc. Has $6.08 Million Stock Position in Incyte Co. (NASDAQ:INCY)

Grimes & Company Inc. lowered its position in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 48.9% during the fourth quarter, HoldingsChannel.com reports. The fund owned 96,755 shares of the biopharmaceutical company’s stock after selling 92,723 shares during the quarter. Grimes & Company Inc.’s holdings in Incyte were worth $6,075,000 at the end of […]

United-states , America , William-blair , Cetera-advisor-networks , Advisor-group , Incyte-co , Dimensional-fund-advisors , A-davidson , Grimes-company-inc , Da-davidson , Nasdaq , Incyte-corporation

Legacy Trust Has $1.83 Million Stock Position in Incyte Co. (NASDAQ:INCY)

Legacy Trust lessened its holdings in Incyte Co. (NASDAQ:INCY – Free Report) by 45.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 29,116 shares of the biopharmaceutical company’s stock after selling 24,472 shares during the period. Legacy Trust’s holdings in […]

United-states , Arizona , China , Canada , America , Marketbeat-incyte , Jefferies-financial-group , International-assets-investment-management , Ballentine-partners , Incyte-co , Exchange-commission

JGP Global Gestao de Recursos Ltda. Has $1.97 Million Position in Incyte Co. (NASDAQ:INCY)

JGP Global Gestao de Recursos Ltda. boosted its stake in Incyte Co. (NASDAQ:INCY – Free Report) by 151.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 31,306 shares of the biopharmaceutical company’s stock after purchasing an additional 18,849 shares during the quarter. Incyte comprises […]

Canada , United-states , Stifel-nicolaus , Vijayk-iyengar , Recursos-ltda , Incyte-co , Nasdaq , Parkside-financial-bank , Exchange-commission , Incyte-corporation , Royal-bank , Sunbelt-securities-inc

Brokerages Set Incyte Co. (NASDAQ:INCY) Price Target at $75.07

Shares of Incyte Co. (NASDAQ:INCY – Get Free Report) have earned an average rating of “Hold” from the fifteen ratings firms that are covering the company, Marketbeat reports. Eight investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year target price […]

United-states , Canada , Blackrock , Nova-scotia , Vijayk-iyengar , Stifel-nicolaus , William-blair , Citigroup , Norges-bank , Securities-exchange-commission , Nasdaq , Incyte-corporation

Incyte's (INCY) Sector Perform Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada reiterated their sector perform rating on shares of Incyte (NASDAQ:INCY – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. The brokerage currently has a $65.00 target price on the biopharmaceutical company’s stock. INCY has been the subject of a number of other reports. William Blair […]

Blackrock , Nova-scotia , Canada , United-states , William-blair , Vijayk-iyengar , Royal-bank , Blackrock-inc , Incyte-company-profile , Jefferies-financial-group , Securities-exchange-commission , Vanguard-group-inc

MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

EQS-News: MorphoSys AG

/ Key word: Annual Report

MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

13.03.2024 / 21:01...

United-states , Planegg , Bayern , Germany , Boston , Massachusetts , Canada , Austria , America , American , German , Thomas-biegi

Trexquant Investment LP Buys 4,584 Shares of Incyte Co. (NASDAQ:INCY)

Trexquant Investment LP boosted its position in Incyte Co. (NASDAQ:INCY – Free Report) by 2.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 161,645 shares of the biopharmaceutical company’s stock after acquiring an additional 4,584 shares during the period. Trexquant Investment […]

Canada , United-states , Blackrock , Nova-scotia , Japan , Vijayk-iyengar , Nasdaq , Renaissance-technologies , Citigroup , Incyte-co , Incyte-corporation

Meiji Yasuda Asset Management Co Ltd. Increases Stock Holdings in Incyte Co. (NASDAQ:INCY)

Meiji Yasuda Asset Management Co Ltd. raised its holdings in Incyte Co. (NASDAQ:INCY – Free Report) by 163.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 29,113 shares of the biopharmaceutical company’s stock after purchasing an additional 18,050 shares during […]

Canada , Japan , Blackrock , Nova-scotia , United-states , Vijayk-iyengar , William-blair , Securities-exchange-commission , Meiji-yasuda-asset-management-co-ltd , Renaissance-technologies , Blackrock-inc , Royal-bank

Meiji Yasuda Asset Management Co Ltd. Purchases 18,050 Shares of Incyte Co. (NASDAQ:INCY)

Meiji Yasuda Asset Management Co Ltd. boosted its position in Incyte Co. (NASDAQ:INCY – Free Report) by 163.2% during the 3rd quarter, Holdings Channel.com reports. The fund owned 29,113 shares of the biopharmaceutical company’s stock after buying an additional 18,050 shares during the quarter. Meiji Yasuda Asset Management Co Ltd.’s holdings in Incyte were worth […]

Canada , Japan , United-states , Stifel-nicolaus , Vijayk-iyengar , William-blair , Incyte-corporation , Northern-trust-corp , Hermes-inc , Nasdaq , Holdings-channel , Incyte-co

CI Investments Inc. Sells 513 Shares of Incyte Co. (NASDAQ:INCY)

CI Investments Inc. trimmed its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 12.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,634 shares of the biopharmaceutical company’s stock after selling 513 shares during the period. CI Investments Inc.’s […]

United-states , Japan , Mizuho , Hokkaido , Stifel-nicolaus , Vijayk-iyengar , William-blair , Mirabella-financial-services , Morgan-stanley , Exchange-commission , Nasdaq , Invesco-ltd